(Sharecast News) - Alliance Pharma posted weaker full-year revenues on Tuesday, but insisted it remained well-positioned for medium-term growth.
The AIM-listed healthcare group, which last month agreed to be taken over by shareholder DBAY Advisors in a £362m deal, posted statutory revenues of £178.8.m in the year to 31 December, down...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE